BiomX (NYSEAMERICAN:PHGE – Get Free Report) is projected to post its quarterly earnings results before the market opens on Wednesday, April 2nd. Analysts expect BiomX to post earnings of ($1.65) per share for the quarter.
BiomX Stock Performance
Shares of BiomX stock opened at $0.58 on Wednesday. BiomX has a 1 year low of $0.48 and a 1 year high of $4.99. The firm has a market capitalization of $10.63 million, a PE ratio of -0.18 and a beta of 1.27.
Analyst Ratings Changes
Separately, HC Wainwright restated a “buy” rating and issued a $2.00 price target on shares of BiomX in a research report on Wednesday, January 8th.
About BiomX
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Featured Stories
- Five stocks we like better than BiomX
- What Are Dividends? Buy the Best Dividend Stocks
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- How to Invest in the FAANG Stocks
- NVIDIA Insiders Sell: This Is What It Means for the Market
- Best Aerospace Stocks Investing
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
